WASHINGTON, May 26 -- Food and Drug Administration has issued a notice called: Advisory Committee; Drug Safety and Risk Management Advisory Committee; Renewal.
The notice was published in the Federal Register on May 26 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA) is announcing the renewal of the Drug Safety and Risk Management Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Drug Safety and Risk Management Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the May 31, 202...